The expression of the MDM2 gene, a p53 binding protein, in thyroid carcinogenesis

Cancer

Volumn 76, Issue 2, 1995, Pages 314-318

  Zou, Minjing ^a   Shi, Yufei ^a   Al‐Sedairy, Sultan ^a   Hussain, Syed S ^a   Farid, Nadir R ^a  

^a KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

Author keywords

gene amplification; gene expression; MDM2; p53; thyroid cancer

Indexed keywords

COMPLEMENTARY DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CARCINOGENESIS; GENE AMPLIFICATION; GENE EXPRESSION REGULATION; GENE MUTATION; GENE REARRANGEMENT; HUMAN; HUMAN CELL; HUMAN TISSUE; PRIORITY JOURNAL; THYROID CANCER;

ADULT; AGED; BASE SEQUENCE; CARCINOMA; DNA PRIMERS; DNA, NEOPLASM; GENE AMPLIFICATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMAN; MIDDLE AGE; MOLECULAR SEQUENCE DATA; PROTO-ONCOGENE PROTEINS; RNA, NEOPLASM; THYROID NEOPLASMS;

EID: 0029009736     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/1097-0142(19950715)76:2<314::AID-CNCR2820760223>3.0.CO;2-Q     Document Type: Article

References (32)

1. A mammalian cell cycle checkpoint pathway utilizing p53 and GADD45 is defective in ataxia‐telangiectasia
2. Presence of a potent transcription activating sequence in the p53 protein
3. Transcriptional activation by wild‐type but not transforming mutants of the p53 anti‐oncogene
4. P53 function and dysfunction
5. P53 mutations in human cancers
6. The p53 tumor suppressor gene
7. The mdm‐2 oncogene product forms a complex with the p53 protein and inhibits p53‐mediated transactivation
8. Oncoprotein MDM2 conceals the activation domain of tumor suppressor p53
9. Wild type p53 can mediate sequence‐specific transactivation of an internal promoter within the mdm2 gene
10. The p53‐mdm‐2 autoregulatory feedback loop
11. Mdm2 expression is induced by wild type p53 activity
12. Amplification of a gene encoding a p53‐associated protein in human sarcomas
13. The mdm‐2 oncogene is translocated and overexpressed in a murine plasmacytoma cell line expressing wild‐type p53
14. P53 mutation and MDM2 amplification in human soft tissue sarcomas
15. MDM2 gene amplification in metastatic osteosarcoma
16. Amplification and overexpression of the MDM2 gene in a subset of human malignant gliomas without p53 mutations
17. Narrow spectrum of infrequent p53 mutations and absence of MDM2 amplification in Ewing tumors
18. Absence of amplification of MDM2 gene, a regulator of p53 function, in myelodysplastic syndromes
19. Accumulation of wild type p53 protein in human astrocytomas
20. P53 mutations in all stages of thyroid carcinomas
21. Molecular basis of thyroid cancer
22. Single‐step method of RNA isolation by acid guanidinium thiocyanate‐phenol‐chloroform extraction
23. High levels of Nm23 gene expression in the advanced stage of thyroid cancer
24. High rates of ras codon 61 mutation in thyroid tumors in an iodide‐deficient area
25. Identification and characterization of multiple mdm‐2 proteins and mdm‐2‐p53 protein complexes
26. The p53‐binding protein MDM2 gene is differentially expressed in human breast carcinoma
27. Molecular abnormalities of mdm2 and p53 genes in adults soft tissue sarcomas
28. TP53 allele loss, mutations and expression in malignant melanoma
29. Tumorigenic potential associated with enhanced expression of a gene that is amplified in a mouse tumor cell line
30. The mdm‐2 oncogene can overcome wild‐type p53 suppression of transformed cell growth